Dragana Bubanja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dragana Bubanja has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Buha Djordjevic
Department of Toxicology “Akademik Danilo Soldatović”, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia
1 shared publication - Ana Banko
Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Ana Starcevic
University of Belgrade
1 shared publication - Anastazija Stojšić-Milosavljević
The Institute for Cardiovascular Diseases of Vojvodina
1 shared publication - Biljana Parapid
Faculty of Medicine - University of Belgrade, Division of Cardiology - University Clinical Center of Serbia, Belgrade, Serbia
1 shared publication Bosiljka Djikanovic-Tetikovic
University of Belgrade, Faculty of Medicine, Institute of Social Medicine and Centre - School of Public Health and Health Management, Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 152 (11-12) , 630-637
Women in science and equity in Serbia - so near, yet so far
The concept of diversity, equity, inclusion and belonging is essential for research and academic programs and institutions worldwide, but although women do not lag behind men at entry and graduation from Serbian universities, equitable leadership does and it further hinders outcomes in every way: from translational science via healthcare up to legislative efforts to protect children, women and elderly. Although all these may seem as l?art-pour-l?art issues when compared to mere survival in war zones on two continents and all issues women face under circumstances of displacement and bans on rights to education, healthcare and sounds of their own voices in public, still it is the ongoing fight for rights lost in silence and where one least expects it that has to push every human being to fight for the oppressed and underprivileged.
- 1 January 2024
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 152 (11-12) , 630-637
Open AccessWomen in science and equity in Serbia - so near, yet so far
The concept of diversity, equity, inclusion and belonging is essential for research and academic programs and institutions worldwide, but although women do not lag behind men at entry and graduation from Serbian universities, equitable leadership does and it further hinders outcomes in every way: from translational science via healthcare up to legislative efforts to protect children, women and elderly. Although all these may seem as l?art-pour-l?art issues when compared to mere survival in war zones on two continents and all issues women face under circumstances of displacement and bans on rights to education, healthcare and sounds of their own voices in public, still it is the ongoing fight for rights lost in silence and where one least expects it that has to push every human being to fight for the oppressed and underprivileged.
- Open Access
- 1 December 2023
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (1) , 146-153
Breast cancer and Graves' disease
Numerous clinical trials have proven the connection between two glandular organs, in this case, the breast and the thyroid gland. The occurrence of breast cancer (BC) is increased in patients with autoimmune thyroid disease (Hashimoto's thyroiditis and Graves' disease). Patients with Graves' disease have a significantly smaller number of described cases of BC than those with diagnosed Hashimoto's thyroiditis. A 57-year-old female patient came to the emergency center with difficulty breathing. During the examination, ophthalmopathy, weakened breath sound and mastitis of both breasts were found. Hormonal analysis showed the following values: TSH 0.00 (0.3-5.5 mlU/L), FT4 32.90 (11.5-23 pmol/L), TSHRAt 19 (0.0-1.1 U/L), TPOAt 234 (0.0-12 IU/ml), TgAt > 2000 (0.0-30.0 IU/ml). A diagnosis of Graves' disease was established and therapy with thyrosuppressant was started immediately. A multi-detector computed tomography (MDCT) showed a left breast tumor with metastases in the supraclavicular and axillary lymph nodes, infiltration of the tumor into the skin and subcutaneous tissue, as well as metastases in the bones. A biopsy of the breast tumor was performed, and PH findings indicated poorly differentiated ductal carcinoma of the breast, the HER-2+ group of tumors. The early detection of thyroid disease would not lead to the development of a malignant process, and that is why doctors in their clinical work must recognize the first signs of thyroid disease in their patients and immediately start with therapy to reduce the potential risk of BC. There is a significant role in using screening tests to discover breast cancer in patients with untreated or inadequately treated hypo-and hyperthyroidism.
- 1 December 2023
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 41 (1) , 146-153
Open AccessBreast cancer and Graves' disease
Numerous clinical trials have proven the connection between two glandular organs, in this case, the breast and the thyroid gland. The occurrence of breast cancer (BC) is increased in patients with autoimmune thyroid disease (Hashimoto's thyroiditis and Graves' disease). Patients with Graves' disease have a significantly smaller number of described cases of BC than those with diagnosed Hashimoto's thyroiditis. A 57-year-old female patient came to the emergency center with difficulty breathing. During the examination, ophthalmopathy, weakened breath sound and mastitis of both breasts were found. Hormonal analysis showed the following values: TSH 0.00 (0.3-5.5 mlU/L), FT4 32.90 (11.5-23 pmol/L), TSHRAt 19 (0.0-1.1 U/L), TPOAt 234 (0.0-12 IU/ml), TgAt > 2000 (0.0-30.0 IU/ml). A diagnosis of Graves' disease was established and therapy with thyrosuppressant was started immediately. A multi-detector computed tomography (MDCT) showed a left breast tumor with metastases in the supraclavicular and axillary lymph nodes, infiltration of the tumor into the skin and subcutaneous tissue, as well as metastases in the bones. A biopsy of the breast tumor was performed, and PH findings indicated poorly differentiated ductal carcinoma of the breast, the HER-2+ group of tumors. The early detection of thyroid disease would not lead to the development of a malignant process, and that is why doctors in their clinical work must recognize the first signs of thyroid disease in their patients and immediately start with therapy to reduce the potential risk of BC. There is a significant role in using screening tests to discover breast cancer in patients with untreated or inadequately treated hypo-and hyperthyroidism.